Hera Logo




Search: projects


Country:
Field of expertise:
Assignment:
Client:
Description:
Order by:
 

Assignment: Medicines Transparency Alliance (MeTA)
Client: DFID
Country: Jordan
Fields of expertise: Access to Medicine Campaigns, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Procurement and Tender Support, Public Private Partnership Interventions, Training and Human Resource Development
Description:Narrative description of Project:

MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices.
The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One.
MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers.

Description of actual services provided by your staff within the assignment:

The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including:
  • Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain;
  • Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement;
  • Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations.
  • Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines.
HERA contracted staff are responsible for the provision of country specific support under META.
Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:2008 - 2010

Assignment: Medicines Transparency Alliance (MeTA)
Client: DFID
Country: Ghana
Fields of expertise: Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Procurement and Tender Support, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:Narrative description of Project:

MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices.
The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One.
MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers.

Description of actual services provided by your staff within the assignment:

The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including:
  • Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain;
  • Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement;
  • Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations.
  • Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines.
HERA contracted staff are responsible for the provision of country specific support under META.
Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:2008 - 2010

Assignment: Medicines Transparency Alliance (MeTA)
Client: DFID
Country: Kyrgyzstan
Fields of expertise: Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:Narrative description of Project:

MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices.
The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One.
MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers.

Description of actual services provided by your staff within the assignment:

The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including:
  • Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain;
  • Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement;
  • Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations.
  • Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines.
HERA contracted staff are responsible for the provision of country specific support under META.
Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:2008 - 2010

Assignment: Medicines Transparency Alliance (MeTA)
Client: DFID
Country: Peru
Fields of expertise: Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:Narrative description of Project:

MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices.
The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One.
MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers.

Description of actual services provided by your staff within the assignment:

The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including:
  • Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain;
  • Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement;
  • Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations.
  • Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines.
HERA contracted staff are responsible for the provision of country specific support under META.
Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:2008 - 2010

Assignment: Medicines Transparency Alliance (MeTA)
Client: DFID
Country: The Philippines
Fields of expertise: Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:Narrative description of Project:

MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices.
The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One.
MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers.

Description of actual services provided by your staff within the assignment:

The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including:
  • Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain;
  • Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement;
  • Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations.
  • Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines.
HERA contracted staff are responsible for the provision of country specific support under META.
Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:2008 - 2010

Assignment: Medicines Transparency Alliance (MeTA)
Client: DFID
Country: Uganda
Fields of expertise: Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:Narrative description of Project:

MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices.
The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One.
MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers.

Description of actual services provided by your staff within the assignment:

The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including:
  • Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain;
  • Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement;
  • Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations.
  • Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines.
HERA contracted staff are responsible for the provision of country specific support under META.
Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:2008 - 2010

Assignment: Medicines Transparency Alliance (MeTA)
Client: DFID
Country: Zambia
Fields of expertise: Access to Medicine Campaigns, Drug Pricing Studies, Drug Regulatory Authority Support, Drug Supply Management System Strengthening, Essential Drugs Programme Support, Essential Medicines Financing, Increasing Transparency In Public And Private Pharmaceutical Markets, National Medicines Policy Development, Public Private Partnership Interventions, Rational Use Surveys, Training and Human Resource Development
Description:Narrative description of Project:

MeTA is a new multi-stakeholder approach for increasing transparency around the selection, procurement, sale and distribution of medicines in Low Income Countries, thereby strengthening governance and encouraging responsible business practices.
The MeTA goal is to ensure access to affordable essential drugs in developing countries (MDG 8, target 17). The initiative us being supported financially by DFID during its present Phase One.
MeTA brings together, at both the international and national levels, a diverse group of people with an interest in the pharmaceutical sector (stakeholders) to find ways to improve information flows, and increase transparency and accountability about the selection, regulation, procurement, sale, distribution and use of medicines in developing countries. By doing so, MeTA will improve how decisions are made about medicines, improve the way they are purchased and supplied, encourage innovative and responsible business practices, and increase the voice of patients and consumers.

Description of actual services provided by your staff within the assignment:

The MeTA International Secretariat is tasked to help to support the implementation of MeTA in 7 pilot countries, through facilitating support for the evolution and effective functioning of the National Secretariats, National Multi-Stakeholder Group (NMSGs), and implementation of work plans. Following the establishment of country MeTA structures, the International MeTA Secretariat provides further support to the pilot countries including:
  • Supporting countries to extract and collate data on medicine quality, availability and pricing along the supply chain;
  • Supporting countries to undertake studies assessing the level of transparency and good governance in medicines regulation and procurement;
  • Working with countries to produce country-specific MeTA reports, which would collate data and further analyse and contextualise issues related to medicine quality, availability and price, and to disseminate these reports through the media and public interest groups; as well as exploring policy options and support needed for implementation e.g. of report recommendations.
  • Assist countries in using the data collated through MeTA on medicine policies and regulation as well as quality, availability and prices to try to promote relevant good practice and policy changes to improve access to medicines.
HERA contracted staff are responsible for the provision of country specific support under META.
Pilot countries are: Ghana, Uganda, Zambia, the Philippines, Jordan, Kyrgyzstan and Peru.
Year:2008 - 2010